611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Streptococcal Throat Infection Linked to Mental DisordersCognitive Decline Linked to Visual Field VariabilityRiboflavin Shows Positive Effect for Migraine in AdultsPromising Results for Drug to Fight Arthritis Linked to PsoriasisKidneys From Deceased Diabetics Might Ease Organ Shortage: StudyNew Cholesterol Fighting Meds Target Key GeneEye Problems May Be Tied to Zika, Lab Study SuggestsATS: Bronchial Thermoplasty Has Lasting Benefits for AsthmaSleepless Nights Could Pose Heart Risk DangersHospital Protocol Helps Thwart Serious InfectionZika Arrived in Florida at Least Four Different WaysKnow the Signs of Thyroid TroubleStudies Spotlight Diet, Supplements for Knee PainFunctional Interaction Seen for Dietary Carbohydrates With AMDTaking Opioids Before Knee Surgery Could Raise Pain LaterATS: First Abx Rx Doesn't Work for ~25% of Pneumonia CasesActemra Approved for Certain Blood Vessel InflammationStudy Casts Doubt on Need for Statins in the 'Healthy Old'First-Try Antibiotics Now Fail in 1 in 4 Adult Pneumonia CasesOvercrowded ERs Risky for Some Seriously Ill PatientsHigh Vitamin K1 Intake Linked to Reduced Cataract RiskPoverty Could Make Lupus Even WorseCDC: Crypto Outbreaks Linked to Pools Have Doubled Since 2014Could Cancer Drug Gleevec Help With Severe Asthma?Zika Mosquito Can Transmit Other Viruses, TooFDA OKs Kalydeco for Additional Mutations in Cystic FibrosisKalydeco Approval Widened for More Types of Cystic FibrosisAnother Step Toward Ebola ProtectionThe Water's Not Fine: U.S. Pool-Linked Infection Doubles in 2 YearsJust 2 Weeks on the Couch Can Trigger Body's DeclineGene Therapy Might Someday Mend Badly Broken Bones'Healthy Obese' May Be a MythNo Evidence Steroids Benefit Symptomatic Knee OsteoarthritisHeart Attack Risk Spikes After Respiratory Infection, Study FindsFor Inflamed Pancreas, Eating Right Away May Be Best MedicineFindings Support More Targeted Approach to Cholesterol ScreensHouston, You Have a 'Superbug'Forget Steroid Shots for Long-Term Relief of Arthritic KneesFDA Approves New Device to Treat Esophageal AtresiaMany U.S. Travelers Skip Measles Shots, Despite Infection RiskMany Under 40 May Not Need Regular Cholesterol Checks: StudyNew Device Approved for Esophageal Birth DefectACP: Recommendations Updated for Low Bone Density TreatmentMosquito-Borne Illnesses May Not Be Limited to TropicsArthroscopy for Degenerative Knees Deemed Seldom EffectiveBioengineered Intraabdominal Endocrine Pancreas FeasibleAllergies Getting Worse? Blame Climate ChangeA 2nd Life for Risky Kidney Transplants?Blood Vessel-Clearing Procedure Riskier on Weekends: StudyMultidrug-Resistant TB Set to Increase Through 2040
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Houston, You Have a 'Superbug'

HealthDay News
by -- Mary Elizabeth Dallas
Updated: May 16th 2017

new article illustration

TUESDAY, May 16, 2017 (HealthDay News) -- A type of bacteria that's resistant to many widely used antibiotics is unusually common among people in Houston, new research reveals.

The superbug, known as Klebsiella pneumoniae, is particularly prevalent in this city of 6 million people, according to scientists.

"Finding the otherwise uncommon strain in our city was a very surprising discovery," said the study's senior author, Dr. James Musser. He is chair of pathology and genomic medicine at Houston Methodist Hospital.

"We urgently need to identify potential vaccine targets or other new treatments, and develop new and rapid diagnostic techniques," he said in a hospital news release.

K. pneumoniae normally lives in the human intestines where it doesn't cause any trouble. However, in other parts of the body and outside the body, the bacteria can cause serious infections.

Hospitalized patients are at particularly high risk for serious infections caused by the germ, the study authors explained.

The bacteria can trigger harmful infections -- such as pneumonia, bloodstream or urinary tract infections, and meningitis -- once it moves out of the intestines and into other parts of the body.

This isn't the first time this year that K. pneumoniae has made the news in the United States. Earlier this year, an elderly Nevada woman died from an infection with this type of bacteria. It was resistant to all 26 antibiotics used in the United States, the researchers said.

For the current study, the researchers sequenced the genome of more than 1,700 strains of Klebsiella pneumoniae bacteria. These strains caused infections in patients treated in the Houston Methodist hospital system from September 2011 to May 2015.

The most abundant strain was called clone type 307. Over the course of those four years, the investigators found K. pneumoniae clone type 307 in more than one-third of the patients studied.

This particular strain has also been identified periodically in Europe, Asia, Africa and South America. But unlike the type that killed the Nevada woman, this strain is still susceptible to some antibiotics, the researchers said.

The study authors don't yet know why this bacteria type seems to have gained a foothold in the Houston area. More research is needed.

"Incorporating sophisticated and novel computational and molecular strategies allowed us to rapidly identify the drug-resistant strains," said the study's first author, Dr. S. Wesley Long. He's associate director of the Clinical Microbiology Laboratory at Houston Methodist Hospital.

"The faster we can successfully identify which antibiotics this strain is sensitive to, the faster a treating physician can target the appropriate therapy to these ill patients," he said.

These tests also help researchers learn how the germ is spreading throughout the Houston area, Long noted.

The findings were published online May 16 in mBio.

More information

The U.S. Centers for Disease Control and Prevention has more about antibiotic-resistant bacteria.